What is the evidence for mast cell activation syndrome?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18749460
Cited by: 0

Abstract

Mast cell activation syndrome is a complicated condition with diagnostic challenges and varying treatment responses. Omalizumab may provide benefit for some patients, though more research is needed to standardize diagnosis and expand treatment options.

Fields of Study & Subjects

Mast cells and histamine Asthma and respiratory diseases Food Allergy and Anaphylaxis Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
23 February 2026
Language
EN